Furosemide
Showing 26 - 50 of 491
Non-Alcoholic Fatty Liver Disease Trial in Giza (conventional treatment, Furosemide or other alternatives , Niaspan or other
Recruiting
- Non-Alcoholic Fatty Liver Disease
- conventional treatment
- +2 more
-
Giza, October 6, EgyptMaha Youssif Fekry
Nov 18, 2023
Pulmonary Edema, CHF, Acute Heart Failure Trial in Copenhagen, Roskilde (Furosemide Injection, Isosorbide Dinitrate, Furosemide
Not yet recruiting
- Pulmonary Edema
- +2 more
- Furosemide Injection
- +2 more
-
Copenhagen, Denmark
- +2 more
Oct 24, 2022
Chronic Kidney Disease, Cardiac Disease Trial in Jakarta (Furosemide, Control)
Completed
- Chronic Kidney Disease
- Cardiac Disease
- Furosemide
- Control
-
Jakarta, IndonesiaNational Cardiovascular Center Harapan Kita Jakarta
Mar 8, 2022
Pre-Eclampsia, Hypertension in Pregnancy, Pregnancy Complications Trial in Honolulu (Furosemide, Placebo)
Completed
- Pre-Eclampsia
- +3 more
- Furosemide
- Placebo
-
Honolulu, HawaiiKapiolani Medical Center for Women and Children
Apr 29, 2022
Heart Failure, Heart Diseases Trial (Ambulatory heart failure management with Flexible Diuretic Regimen with furosemide,
Not yet recruiting
- Heart Failure
- Heart Diseases
- Ambulatory heart failure management with Flexible Diuretic Regimen with furosemide
- Ambulatory heart failure management with fixed dose furosemide
- (no location specified)
Nov 4, 2022
BPH With Urinary Obstruction, BPH, Hematuria Trial (Furosemide)
Not yet recruiting
- BPH With Urinary Obstruction
- +3 more
- Furosemide
- (no location specified)
Jan 23, 2023
Urolithiasis, Nephrolithiasis, Urinary Calculi Trial in Shiraz (Furosemide 40 mg, Conventional Treatment)
Recruiting
- Urolithiasis
- +3 more
- Furosemide 40 mg
- Conventional Treatment
-
Shiraz, Fars, Iran, Islamic Republic ofShahid Faghihi Hospital
Feb 26, 2022
End Stage Renal Disease on Dialysis Trial in Edmonton (Furosemide, Chlorthalidone)
Recruiting
- End Stage Renal Disease on Dialysis
- Furosemide
- Chlorthalidone
-
Edmonton, Alberta, CanadaUniversity of Alberta
Jun 13, 2023
Salt-Sensitivity of Blood Pressure Trial (Furosemide (Diuretic), Hypertonic Saline Infusion)
Not yet recruiting
- Salt-Sensitivity of Blood Pressure
- Furosemide (Diuretic)
- Hypertonic Saline Infusion
- (no location specified)
Oct 17, 2023
Nephrotic Syndrome, Edema, Sodium Retention Trial in Tuebingen (Amiloride, Furosemide)
Recruiting
- Nephrotic Syndrome
- +2 more
- Amiloride
- Furosemide
-
Tuebingen, Baden-Wuerttemberg, GermanyUniversity Hospital Tuebingen
Nov 1, 2022
Kidney Stone Trial (Furosemide 40 mg)
Not yet recruiting
- Kidney Stone
- Furosemide 40 mg
- (no location specified)
Jun 14, 2023
Fluid Overload, Heart Failure Acute Trial in Baltimore (Metolazone 60 minutes prior to furosemide, Metolazone concurrently with
Terminated
- Fluid Overload
- Heart Failure Acute
- Metolazone 60 minutes prior to furosemide
- Metolazone concurrently with furosemide
-
Baltimore, MarylandUniversity of Maryland Medical Center
Sep 25, 2021
Chronic Kidney Failure Trial in Mexico City (Furosemide)
Recruiting
- Chronic Kidney Failure
- Furosemide
-
Mexico City, MexicoInstituto Nacional de Cardiologia Ignacio Chávez
Oct 22, 2021
Heart Failure; With Decompensation Trial in Rochester (Bumetanide, Furosemide)
Not yet recruiting
- Heart Failure; With Decompensation
- Bumetanide
- Furosemide
-
Rochester, MinnesotaMayo Clinic in Rochester
Sep 7, 2023
Lung Injury in COVID-19: Treatment With Furosemide and Negative
Completed
- COVID-19
-
Mar del Plata, Buenos Aires, ArgentinaClínica Colón
Apr 20, 2022
Drug Use Trial in Jakarta Pusat (Furosemide 40 mg, Lasix® 40 mg Tablet)
Completed
- Drug Use
- Furosemide 40 mg
- Lasix® 40 mg Tablet
-
Jakarta Pusat, DKI Jakarta, IndonesiaPT Pharma Metric Labs
Aug 4, 2021
Heart Failure Trial in DeLand (Furosemide Injection Solution for subcutaneous administration (80 mg), Furosemide Injection, USP,
Completed
- Heart Failure
- Furosemide Injection Solution for subcutaneous administration (80 mg)
- +2 more
-
DeLand, FloridaAccel Research Sites - DeLand Clinical Research Unit
Sep 14, 2021
Bronchopulmonary Dysplasia Trial in United States (Furosemide (plus potassium chloride), Placebo (plus electrolyte solution))
Not yet recruiting
- Bronchopulmonary Dysplasia
- Furosemide (plus potassium chloride)
- Placebo (plus placebo electrolyte solution)
-
Atlanta, Georgia
- +3 more
Jun 1, 2023
Postpartum Pregnancy-Induced Hypertension, Postpartum Preeclampsia, Hypertension, Pregnancy-Induced Trial in New York
Completed
- Postpartum Pregnancy-Induced Hypertension
- +3 more
- Furosemide
- Placebo
-
New York, New YorkColumbia University Irving Medical Center
Oct 7, 2022
Furosemide Depending on Albumin Function
Not yet recruiting
- Acute Renal Failure
- Critical Illness
- albumin function analysis (ABIC)
-
Rostock, Mecklenburg Vorpommern, GermanyUniversity Hospital Rostock
Jul 22, 2021
Bronchopulmonary Dysplasia Trial in United States (Furosemide Cohort 1, Furosemide Cohort 2, Furosemide Cohort 3)
Completed
- Bronchopulmonary Dysplasia
- Furosemide Cohort 1
- +3 more
-
Little Rock, Arkansas
- +20 more
Nov 29, 2021
Sickle Cell Disease Trial in San Antonio (Voxelotor, Bupropion, Repaglinide)
Recruiting
- Sickle Cell Disease
- Voxelotor
- +8 more
-
San Antonio, TexasICON Early Phase Services, LLC
Jul 31, 2023
Acute Heart Failure, Congestion, Heart Failure Trial in Wroclaw (Furosemide intravenous infusion, Continous intravenous infusion
Recruiting
- Acute Heart Failure
- +2 more
- Furosemide intravenous infusion
- +2 more
-
Wroclaw, Lower Silesia, PolandInstitute of Heart Diseases, Wroclaw Medical University
Jul 23, 2023